Home > Business > Market Report > Technicals
Trading strategy for May 14
Hemen Kapadia/ Morpheus Inc |
May 13, 2003 21:28 IST
The market has just about improved while the previously mentioned divergence very much apparent. Mid-cap stocks shot through the roof while mainline stocks continued to falter. The star of the day (besides the Capital Goods, FMCG, PSU's) was undoubtedly the textile sector, volume was better while the undertone was hopeful.
Sensex -- Last Close: 2960.62 | Support: 2922, 2826 | Resistance: 3007, 3110
Trading Range -- The Sensex opened at 2947.03, moved up to an intra-day high of 2964.96, declined to an intra-day low of 2947.03 and closed at 2960.62.
Review/Outlook -- The Sensex has reflected indecision by staying within the previous day's trading range while a positive closing and the intra-day charts would seem to suggest a further upside today.
ABB -- Last Close: 319.65 | Support: 318, 306 | Resistance: 330, 350
Trading Range -- The scrip opened at 310.00, moved up to an intra-day high of 324.45, declined to an intra-day low of 310.00 and closed at 319.65.
Review/Outlook -- The scrip has given an upward 'key' reversal (bullish intra-day pattern) and has also sustained above the 10 and 55 day averages while a further upside seems possible.
HLL -- Last Close: 140.50 | Support: 127, 111 | Resistance: 141, 155
Trading Range -- The scrip opened at 138.40, moved up to an intra-day high of 140.95, declined to an intra-day low of 138.00 and closed at 140.50.
Review/Outlook -- The scrip has closed above a supply line and with the mechanical indicators supporting the move, a further upside cannot be ruled out.
NIIT -- Last Close: 130.25 | Support: 126, 113 | Resistance: 139, 161
Trading Range -- The scrip opened at 126.75, moved up to an intra-day high of 131.50, declined to an intra-day low of 125.50 and closed at 130.25.
Review/Outlook -- The scrip has bounced back after taking support on the 126 level and with the oscillators in a positive frame of mind, further appreciation seems to be on the cards.
Pfizer -- Last Close: 343.60 | Support: 340, 327 | Resistance: 355, 378
Trading Range -- The scrip opened at 338.00, moved up to an intra-day high of 345.00, declined to an intra-day low of 336.55 and closed at 343.60.
Review/Outlook -- The scrip has closed above the 340 level after some amount of 'working' (which includes taking support on the 55 day average) and with the oscillators supporting the move, a further upside cannot be ruled out.
Scrip | Support | Last Close | Resistance | Trend | ACC | 127, 115 | 131.20 | 135, 143 | Sd | HLL | 127, 111 | 140.50 | 141, 155 | Tu | INFOSYS | 2405, 1897 | 2873.75 | 2985, 3468 | Td | ITC | 665, 592 | 670.50 | 729, 802 | Sd | MTNL | 95, 85 | 100.25 | 103, 115 | Tu | RIL | 242, 217 | 261.60 | 269, 302 | Dt | SATYAM | 149, 113 | 168.35 | 173, 199 | Sd | SBI | 276, 258 | 292.65 | 293, 314 | Tu | TELCO | 148, 135 | 156.80 | 168, 186 | Tu | TISCO | 131, 125 | 134.80 | 139, 150 | Tu | GLOSSARY : CMP - Current Market Price, MACD - Moving Average Convergence Divergence, RMI - Relative Momentum Index, RSI - Relative Strength Index, ROC - Rate of Change, EMA - Exponential Moving Average, CMP - Current Market Price, Cls - Closing Price, Support - Level where buying can be expected, Resistance - Level where selling can be expected, Tu - Turning Upwards, Td - Turning Downwards, Sd - Sideways, Up - Uptrend, Dt -Downtrend. | DISCLAIMER : While efforts have been made to ensure the accuracy of the information provided in this content, the authors shall not be held responsible for any loss, harm or injury arising in any manner whatsoever, including those arising directly, indirectly, consequentially or otherwise and whether financial, mental or otherwise, caused to any person whatsoever who accesses or uses or is supplied with the content (consisting of articles, information, analyses, etc.) provided at this site or who otherwise relies on such content. Readers are advised to cross verify the information and to also seek professional and expert advice before taking any decision based on the content provided above or acting on any recommendations made herein. The information or opinions provided herein are not a substitute for professional advice. Sebi Disclosure: The author has no positions in the stocks mentioned above |
|